Intas Pharmaceuticals Limited (manufacturing of finished medicinal product, primary, secondary packaging, quality control of batch)

The drug is used for monotherapy in patients with metastatic ovarian cancer (after first-line chemotherapy) or recurrent small cell lung cancer. It is also used in combination with cisplatin for the treatment of recurrent cervical cancer.

Dosage form: concentrate for infusion solution

ATC: L01CE01